AstraZenca Pharma India Ltd (ASTRAZEN)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 9073.00
% Change: 0.80% (Prev Close: 9001.00)

Volume: 10,708
% Change: -13.51% (Prev Volume: 12,381)

Delivery: 4,592
Delivery % : 42.88
% Change: -6.42% (Prev Delivery: 4,907)

Turnover: 970 Lacs
% Change: -13.32% (Prev Turnover: 1,119)

πŸ’Ή EOD Valuation

P/E Ratio: 123.71
P/B Ratio: 29.44
Market Cap: 22683 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ASTRAZEN
Market Cap: 21151 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 10691.00
52 Week Low: 6220.00

All-Time High: 10691.00 Rs.
All-Time Low: 298.40 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
2.70% | -7.10% | 21.78% | 31.81% | 43.92%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 75.00%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 3.03%

Change (3Y | 1Y): 0.55% | 0.14%

DII Holding

DII Holding: 4.55%

Change (3Y | 1Y): 3.25% | -0.10%

Public Holding: 17.41%

🏦 Financial Strength

Debt to Equity: 0.05
Debt: 35.73 Rs. Cr.

Book Value: 308.14 Rs.
Current Ratio: 1.91
Interest Coverage: 139.07
Free Cash Flow: 64.32 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 33.69%

Sales Growth Qtr (YOY | QoQ):
35.81% | 9.54%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
15.59% | 28.67% | 33.69%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 61.41%

Profit Growth Qtr (YOY | QoQ):
60.14% | -4.15%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
19.45% | 43.27% | 61.41%

EPS Rs.

EPS (TTM): 73.34 Rs.

EPS Qtr (Last Year | Latest):
-4.72 Rs. | 22.33 Rs.

EPS Annual (Last Annual | Annual March):
64.60 Rs. | 46.30 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
19.45% | 43.27%

Net Profit Rs. Cr.

Net Profit (TTM): 183.36 Rs. Cr.

Net Profit (Annual - March): 115.74 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-11.79| 58.25 | 55.83

EBITDA Rs. Cr.

EBITDA (Quarter): 92.35 Rs. Cr.
EBITDA (Previous Yr Ql): 46.42 Rs. Cr.

EBITDA (Annual - March): 294.28 Rs. Cr.
EBITDA (Previous Annual): 219.22 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
17.14% | 44.21%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 16.01%

OPM Qtr (Previous | Current):
17.98% | 15.41%

OPM Annual (5 Yrs | Last Yr | March):
14.65% | 14.24% | 14.80%

Return on Equity %

ROE: 23.63%

ROE (5 Yrs | 3 Yrs | Last Yr):
21.22% | 23.20% | 22.92%

Return on Capital Employed %

ROCE: 33.40%

ROCE (5 Yrs | 3 Yrs | Last Yr):
28.34% | 31.81% | 31.13%

Return on Assets %

ROA (TTM): 13.49%

ROA (5 Yrs | 3 Yrs | Last Yr):
12.27% | 13.89% | 14.45%

PEG Ratio: 2.31
Dividend Yield: 0.38%

PE 3 Yrs: 94.10
PE 5 Yrs: 107.37

Dividend Yield: 0.38%

πŸ‘₯ Company

AstraZenca Pharma India Ltd

ASTRAZEN

Promoter Holding: %